Late-onset Huntington’s disease – an overlooked diagnosis

Česká verzia

Authors: P. Ressner; P. Bártová; J. Horáková; P. Krulová; V. Jaremová; D. Beránková; M. Bar
Authors place of work: Neurologická klinika FN Ostrava
Published in the journal: Cesk Slov Neurol N 2018; 81(4): 484-486
Category: Letters to Editor
doi: https://doi.org/10.14735/amcsnn2018484

Summary

The authors declare they have no potential confl icts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manu script met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Roth J. Huntingtonova nemoc. Cesk Slov Neurol N 2010; 73/106 (2): 107–123.

2. Chaganti SS, McCruscer EA, Loy CT. What we know about late onset Huntington’s disease? J Huntington Dis 2017; 6 (2): 95–103. doi: 10.3233/JHD-170247.

3. Sun YM, Zhang YB, Wu ZY. Huntington's disease: relationship between phenotype and genotype. Mol Neurobiol 2017; 54(1): 342–348. doi: 10.1007/s12035-015-9662-8.

5. Walker FO. Huntington‘s disease. Lancet 2007; 369 (9557): 218–228.

6. Myers R. Huntington disease genetics. Neuro RX 2004; 1 (2): 255–262. doi: 10.1602/neurorx.1.2.255.

7. Klempíř J, Židovská J, Stochl J et al. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington‘s disease. Mov Disord 2011; 26 (1): 125–129. doi: 10.1002/mds.23436.

8. Aylward EH, Nopoulos PC, Ross CA et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 2011; 82 (4): 405–410. doi: 10.1136/jnnp.2010.208 264.

9. Klempíř J, Mikulenková D, Písačka M et al. Diferenciální diagnostika neuroakantocytóz. Cesk Slov Neurol N 2009; 72/105 (1) : 24–29.